ANDA 87032, held by Wockhardt. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 87032 (Chlorpromazine Hydrochloride), held by Wockhardt, was first approved by FDA on Jul 8, 1982, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 8, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride30MG/ML ยท concentrate;oral | Chlorpromazine Hydrochloride | Discontinued |
| Mar 30, 1990 | Supplement 14Labeling | Approved | None posted |
| Nov 30, 1989 | Supplement 12Labeling | Approved | None posted |
| Jun 21, 1989 | Supplement 13Labeling | Approved | None posted |
| Jul 28, 1988 | Supplement 9Manufacturing | Approved | None posted |
| Jul 28, 1988 | Supplement 10Manufacturing | Approved | None posted |
| Jul 28, 1988 | Supplement 11Manufacturing | Approved | None posted |
| May 18, 1987 | Supplement 5Manufacturing | Approved | None posted |
| Aug 7, 1985 | Supplement 3Manufacturing | Approved | None posted |
| Jul 8, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters